Cite
MLA Citation
Martin H. Voss et al.. “A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.” Cancer, vol. 125, no. 14, 2019, pp. 2400–2408. http://access.bl.uk/ark:/81055/vdc_100086830350.0x00005c